Skip to content
LexBuild

Risk Communication Advisory Committee; Notice of Postponement of Meeting

---
identifier: "/us/fr/2014-01312"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Risk Communication Advisory Committee; Notice of Postponement of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2014-01312"
section_name: "Risk Communication Advisory Committee; Notice of Postponement of Meeting"
positive_law: false
currency: "2014-01-23"
last_updated: "2014-01-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2014-01312"
document_type: "notice"
publication_date: "2014-01-23"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "79 FR 3830"
fr_volume: 79
docket_ids:
  - "Docket No. FDA-2014-N-0001"
fr_action: "Notice."
---

#  Risk Communication Advisory Committee; Notice of Postponement of Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is postponing the meeting of the Risk Communication Advisory Committee scheduled for February 3 and 4, 2014. The meeting was announced in the *Federal Register* of January 3, 2014 (79 FR 398). The meeting is postponed due to unavoidable operational changes. Future meeting dates will be announced in the *Federal Register.*

**FOR FURTHER INFORMATION CONTACT:**

Luis G. Bravo, Office of Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3274, Silver Spring, MD 20993, 240-402-5274, or email: *[email protected]* or FDA Advisory Committee Information  Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). Please call the Information Line for up-to-date information on this meeting.

Dated: January 17, 2014.

Leslie Kux,

Assistant Commissioner for Policy.